mirtazapine and risperidone

mirtazapine has been researched along with risperidone in 42 studies

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (2.38)18.2507
2000's16 (38.10)29.6817
2010's22 (52.38)24.3611
2020's3 (7.14)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY1
Alonso, JM; Andrés, JI; Cid, JM; Díaz, A; Fernández, J; Gil, P; Iturrino, L; Megens, A; Sipido, VK; Trabanco, AA1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Kenny, PW; Toulmin, A; Wood, JM1
Ahman, M; Holmén, AG; Wan, H1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Claxton, CR; Curran, RE; Harradine, PJ; Hutchison, L; Littlewood, P; Martin, IJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Doorschot, CH; Loonen, AJ; Oostelbos, MC; Sitsen, JM1
Blass, DM; Pearson, VE1
Danileviciūte, V1
Canale, A; Crucitti, D; D'Arrigo, C; Malara, G; Muscatello, MR; Spina, E; Torre, DL; Zoccali, R1
Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB1
Chandra, PS; Chaturvedi, SK; Gupta, A; Prabhu, SC; Ranjan, S1
Argiriou, S; Knopf, U; Kuwilsky, A; Zink, M1
Abbasi, SH; Akhondzadeh, S; Behpournia, H; Ghoreshi, A; Raznahan, M; Rezaei, F; Rezazadeh, SA; Salehi, B1
Cho, SJ; Choi, TK; Kim, B; Kim, YW; Lee, JE; Lee, KS; Lee, SH; Suh, S; Yook, K; Yook, KH1
Lai, CH1
Gądek-Michalska, A; Kabziński, M; Rachwalska, P; Rogóż, Z; Sadaj, W1
Rogóż, Z2
Gołembiowska, K; Kamińska, K; Rogóż, Z1
Kamińska, K; Rogóż, Z1
Khouzam, HR1
Bonse, A; Hempel, G; Lingg, R; Oberfeld, S; Telger, K; Weber, J1
Hastings, M; May, T; Urbina, TM1
Kamińska, K; Pańczyszyn-Trzewik, P; Rogóż, Z; Sowa-Kućma, M1
Akagawa, Y; Ikeda, J; Ishii, W; Sekijima, Y; Shishido-Hara, Y; Ueno, A1
Górska, A; Gołembiowska, K; Kamińska, K; Noworyta-Sokołowska, K; Rogóż, Z; Wojtas, A1
Deckert, J; Hommers, LG; Menke, A; Samanski, L; Scherf-Clavel, M; Unterecker, S1
Al Abdulla, M; Haddad, PM; Iqbal, Y; Latoo, J1
Hefner, G; Klimke, A; Reißner, P; Toto, S; Wolff, J1
Grover, S; Sahoo, S; Sarkar, S1

Reviews

4 review(s) available for mirtazapine and risperidone

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:11

    Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors

2002
Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
    Postgraduate medicine, 2016, Volume: 128, Issue:3

    Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bupropion; Chronic Pain; Humans; Mianserin; Mirtazapine; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Thiazoles; Trazodone; Triazoles

2016
Augmentation strategies for clozapine resistance: a systematic review and meta-analysis.
    Acta neuropsychiatrica, 2023, Volume: 35, Issue:2

    Topics: Antipsychotic Agents; Clozapine; Humans; Mirtazapine; Risperidone; Schizophrenia

2023

Trials

3 trial(s) available for mirtazapine and risperidone

ArticleYear
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 10, Issue:1

    Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Isoxazoles; Male; Mianserin; Middle Aged; Mirtazapine; Paliperidone Palmitate; Pilot Projects; Psychotic Disorders; Pyrimidines; Risperidone; Severity of Illness Index; Treatment Outcome

1999
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial.
    Schizophrenia research, 2010, Volume: 116, Issue:2-3

    Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Risperidone; Schizophrenia; Treatment Outcome; Young Adult

2010
Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jan-15, Volume: 35, Issue:1

    Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cognition Disorders; Double-Blind Method; Drug Synergism; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Schizophrenia

2011

Other Studies

35 other study(ies) available for mirtazapine and risperidone

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents.
    Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Furans; Heterocyclic Compounds, 4 or More Rings; Humans; In Vitro Techniques; Mice; Psychotropic Drugs; Radioligand Assay; Rats; Stereoisomerism; Structure-Activity Relationship

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Toward prediction of alkane/water partition coefficients.
    Journal of medicinal chemistry, 2008, Jul-10, Volume: 51, Issue:13

    Topics: Alkanes; Central Nervous System; Molecular Structure; Static Electricity; Surface Properties; Water

2008
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
    Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6

    Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Physical binding pocket induction for affinity prediction.
    Journal of medicinal chemistry, 2009, Oct-08, Volume: 52, Issue:19

    Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
Control and measurement of plasma pH in equilibrium dialysis: influence on drug plasma protein binding.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3

    Topics: Animals; Blood Proteins; Buffers; Carbon Dioxide; Chemical Phenomena; Dialysis; Dogs; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Macaca fascicularis; Mice; Osmolar Concentration; Pharmaceutical Preparations; Protein Binding; Rats; Reproducibility of Results

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
SIADH with multiple antidepressants in a geriatric patient.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:6

    Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2000
Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.
    Pharmacological research, 2003, Volume: 48, Issue:4

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Clinical Trials as Topic; Clozapine; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Italy; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors

2003
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2003, Volume: 103, Issue:11

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride

2003
Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:4

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Mianserin; Mirtazapine; Olanzapine; Risperidone; Serotonin Antagonists; Treatment Outcome

2006
A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:5

    Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Comorbidity; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; Mianserin; Mirtazapine; Pulmonary Embolism; Rhabdomyolysis; Risperidone; Schizophrenia

2006
Dissociative identity disorder may be relieved by the combined treatments of mirtazapine and risperidone: case report of an adolescent.
    The Journal of neuropsychiatry and clinical neurosciences, 2012,Spring, Volume: 24, Issue:2

    Topics: Adolescent; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Dissociative Identity Disorder; Drug Therapy, Combination; Female; Humans; Mianserin; Mirtazapine; Risperidone

2012
Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
    Pharmacological reports : PR, 2012, Volume: 64, Issue:6

    Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Exploratory Behavior; Fluoxetine; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Swimming

2012
Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.
    Pharmacological reports : PR, 2012, Volume: 64, Issue:6

    Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Dextroamphetamine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hyperkinesis; Male; Mianserin; Mice; Mirtazapine; Motor Activity; Risperidone; Schizophrenia; Schizophrenic Psychology

2012
Effect of combined treatment with mirtazapine and risperidone on the MK-801-induced changes in the object recognition test in mice.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:5

    Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Brain; Cognition; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Mianserin; Mice; Mirtazapine; Motor Activity; Receptors, N-Methyl-D-Aspartate; Recognition, Psychology; Risperidone

2013
The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:6

    Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Frontal Lobe; Injections, Intraperitoneal; Mianserin; Microdialysis; Mirtazapine; Norepinephrine; Piperazines; Pyridines; Rats; Risperidone; Serotonin

2014
The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats.
    Pharmacological reports : PR, 2015, Volume: 67, Issue:6

    Topics: Animals; Antidepressive Agents; Citalopram; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Synergism; Male; Mianserin; Mirtazapine; Rats; Risperidone; Social Behavior

2015
Validation of a dried blood spot method for therapeutic drug monitoring of citalopram, mirtazapine and risperidone and its active metabolite 9-hydroxyrisperidone using HPLC-MS.
    Journal of pharmaceutical and biomedical analysis, 2017, Jun-05, Volume: 140

    Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Citalopram; Dried Blood Spot Testing; Drug Monitoring; Humans; Mianserin; Mirtazapine; Paliperidone Palmitate; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry

2017
Navigating Undiagnosed Dissociative Identity Disorder in the Inpatient Setting: A Case Report.
    Journal of the American Psychiatric Nurses Association, 2017, Volume: 23, Issue:3

    Topics: Adaptation, Psychological; Adult; Antidepressive Agents; Antipsychotic Agents; Cognitive Behavioral Therapy; Dissociative Identity Disorder; Female; Hospitalization; Humans; Inpatients; Mianserin; Mirtazapine; Risperidone; Sertraline; Treatment Outcome

2017
Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats.
    Pharmacological reports : PR, 2017, Volume: 69, Issue:5

    Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Drug Interactions; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Hippocampus; Mianserin; Mirtazapine; Rats; Rats, Wistar; Risperidone; RNA, Messenger; Serotonin Antagonists

2017
[Two patients with progressive multifocal leukoencephalopathy with immune response against JC virus showing good long-term outcome by combination therapy of mefloquine, mirtazapine, and risperidone].
    Rinsho shinkeigaku = Clinical neurology, 2018, May-25, Volume: 58, Issue:5

    Topics: Adult; Brain; Drug Therapy, Combination; Female; Humans; Immunity, Cellular; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Mefloquine; Mianserin; Middle Aged; Mirtazapine; Risperidone; Time Factors; Treatment Outcome

2018
The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:5

    Topics: Animals; Antidepressive Agents; Catalepsy; Citalopram; Dopamine; Drug Synergism; Frontal Lobe; Locomotion; Male; Mianserin; Mirtazapine; Rats; Recognition, Psychology; Risperidone; Serotonin

2018
Analysis of smoking behavior on the pharmacokinetics of antidepressants and antipsychotics: evidence for the role of alternative pathways apart from CYP1A2.
    International clinical psychopharmacology, 2019, Volume: 34, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Antipsychotic Agents; Clozapine; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Desvenlafaxine Succinate; Doxepin; Drug Monitoring; Female; Glucuronosyltransferase; Humans; Male; Middle Aged; Mirtazapine; Nortriptyline; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Smoking; Venlafaxine Hydrochloride

2019
Brief psychotic disorder associated with quarantine and mild COVID-19.
    BMJ case reports, 2020, Dec-16, Volume: 13, Issue:12

    Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; COVID-19; Humans; Lorazepam; Male; Mirtazapine; Pandemics; Psychotic Disorders; Qatar; Quarantine; Risperidone; SARS-CoV-2

2020
Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry.
    Journal of neural transmission (Vienna, Austria : 1996), 2022, Volume: 129, Issue:11

    Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Female; Humans; Male; Mental Disorders; Middle Aged; Mirtazapine; Off-Label Use; Olanzapine; Psychiatry; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Retrospective Studies; Risperidone; Valproic Acid

2022